Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B4ZQ
|
||||
Former ID |
DIB001411
|
||||
Drug Name |
SL-90.0571
|
||||
Indication | Epilepsy [ICD10:G40] | Discontinued in Phase 1 | [545133] | ||
Company |
Synthelabo
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c12c(C3COC(OC3)CCCNC(=O)C)cccc1cc(cc2)OC
|
||||
CAS Number |
CAS 139293-31-5
|
||||
Target and Pathway | |||||
Target(s) | Sodium channel | Target Info | Modulator | [550935] | |
KEGG Pathway | Dopaminergic synapse | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.